iMetabolic Biopharma

Growth Stage

Bringing Hope to Communities Through Tech-Powered Biopharma.

Overview

Raised to Date: Raised: $246,816

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/19/2022

Close Date

03/16/2023

Min. Goal

$10,000

Max. Goal

$1,230,000

Min. Investment

$250

Security Type

Convertible Note

Series

Seed

Funding Type

RegCF

Valuation Cap

$25,000,000

Discount Rate

10%

Rolling Commitments ($USD)

Status

Active

Reporting Date

02/01/2023

Days Remaining

43

% of Min. Goal

2,468%

% of Max. Goal

20%

Likelihood of Max
unlikely
Avg. Daily Raise

$5,609

# of Investors

205

Momentum
cool.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Tempe, Arizona

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

IMetabolic Biopharma, with a valuation of $25 million, is raising funds on StartEngine. It is an early-stage drug discovery company developing new, life-saving drugs to fight against some of today's most devastating chronic diseases. IMetabolic Biopharma technology-powered iPlatform™ pipeline removes the roadblocks that typically make drug development slow, expensive, and inefficient. Currently the company is pre-market. Urban Austin Kiernan founded the company in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,230,000. The campaign proceeds will be used for Therapeutic asset research and development, software research and development, executive compensation and working capital.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-63,745

$-22,130

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$64,248

$119,176

Accounts Receivable

$0

$0

Total Assets

$64,248

$119,176

Short-Term Debt

$17,192

$3,139

Long-Term Debt

$139,336

$148,000

Total Liabilities

$156,528

$151,139

Financials as of: 12/19/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
iMetabolic Biopharma on StartEngine 2022
$
Platform: StartEngine
Security Type: Convertible Note
Valuation: $25,000,000

Follow company

Follow iMetabolic Biopharma on StartEngine 2022
View on StartEngine